Market Overview

Global Drug Discovery Market Report 2018: Technologies, Market share and Industry Forecasts 2017-2024 - ResearchAndMarkets.com

Share:

The "Global
Drug Discovery Market-Technologies, Market share and Industry Forecast
to 2024"
report has been added to ResearchAndMarkets.com's
offering.

Global drug discovery market was valued at $38,356 million in 2017 and
is estimated to generate net revenue of approximately $70,097 million by
2024 growing at a CAGR of 9.0% during forecast period (2017-2024).

The market for the global drug discovery is highly affected due to the
scientific and technological changes and advancements that are
continuously taking place around the world. This market contributes
highly in the growth of whole pharmaceutical industry as they help in
introduction of new drugs.

Adoption of global drug discovery market is driven by following factors,
such as rising incidences of chronic diseases, rising demand for novel
drug discovery technologies and advancement in field of biotechnology.

The factors that restrain the growth of the global drug discovery market
are the slow growth and development of new drugs may hamper the growth
of this market. Also, the expiry of patents of the major drugs and the
huge cost and time factor that is involved in the drug discovery hamper
the growth of the global drug discovery market.

North America leads the global market for drug discovery due to the
presence of manufacturing and research facilities in the region; also,
it is the largest consumer of the branded drugs. This region is most
lucrative as large number of leading pharmaceutical company's presence.
North America countries such as U.S. and Canada have formulated policies
for encouraging investors for research in drug development and discovery.

Asia Pacific market is driven by rise in the number contract research
organizations. Asia-pacific is fastest growing region due to the
presence of skilled labor at affordable cost, rise in disposable income
and favorable government policies are also contributing in the market
growth.

Global drug discovery market involves the process by which medications
are discovered. These drugs are discovered by identifying the active
ingredient by serendipitous discovery. The report scope of global drug
discovery market covers segmentation analysis of drug type, technology,
service and end-user. Drug type segment of global drug discovery market
includes: small molecule drug and biologics drug.

Technology segment of global drug discovery market includes: high
throughput screening, biochips, bioinformatics, pharmacogenomics and
pharmacogenetics, combinatorial chemistry, nanotechnology, spectroscopy,
metabolomics and other technologies.

Service segment of global drug discovery market includes: Drug
Metabolism and Pharmacokinetics (DMPK) services, pharmaceutical
services, chemical services and biological services. End-user segment of
global drug discovery market includes: research institutes,
pharmaceutical companies, biotechnology companies and other end users.

Major players present in the market includes Pfizer (U.S.),
GlaxoSmithKline PLC (UK), Johnson and Johnson (U.S), Bayer (Germany) and
others. Further, presence of these major players in the market is
expected to increase the opportunity for innovation in the field of
global drug discovery market. Mergers & acquisitions, product launches,
etc. are the major strategies adopted for expansion of business in
global drug discovery market.

Key Topics Covered:

1. Introduction

2. Market Overview

3. Market Determinants

4. Global Drug Discovery Market By Drug Type

5. Global Drug Discovery Market By Technology

6. Global Drug Discovery Market By Service

7. Global Drug Discovery Market By End User

8. Competitive Landscape

9. Geographic Analysis

10. Company Profiles

  • Albany Moleculer Research (U.S.)
  • Astrazeneca (U.K)
  • Bayer (Germany)
  • Boehringer Ingelheim (Germany)
  • Covance. (U.S.)
  • Cyprotex. (U.K.)
  • Eli Lily (U.S)
  • Genscript (U.S)
  • Glaxosmithkline Plc (UK)
  • Johnson And Johnson (U.S)
  • Pfizer, Inc. (U.S.)
  • Quintiles (U.S)
  • Viva Biotech (China)
  • WIL Research Laboratories (U.S.)
  • WuXi Apptech (China)

For more information about this report visit https://www.researchandmarkets.com/research/gxpl52/global_drug?w=4

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com